Related references
Note: Only part of the references are listed.NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Claudio Mauro et al.
NATURE CELL BIOLOGY (2011)
Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines
Stephan Hailfinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism
Prashanth Ak et al.
FASEB JOURNAL (2010)
被撤回的出版物: The Skp2 Promoter Integrates Signaling through the NF-κB, p53, and Akt/GSK3β Pathways to Regulate Autophagy and Apoptosis (Retracted article. See vol. 55, pg. 342, 2014)
Benjamin Barre et al.
MOLECULAR CELL (2010)
RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor-κB Alternative Pathway in Tumorigenicity
Yong Xu et al.
CANCER RESEARCH (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP
Yifeng Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
NF-κB and cancer -: identifying targets and mechanisms
Willscott E. Naugler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Nuclear factor-κB, an unappreciated tumor suppressor
Fei Chen et al.
CANCER RESEARCH (2007)
Reduction in IκB kinase α expression promotes the development of skin papillomas and carcinomas
Eunmi Park et al.
CANCER RESEARCH (2007)
Epigenetic inactivation of lκB kinase-α in oral carcinomas and tumor progression
Genta Maeda et al.
CLINICAL CANCER RESEARCH (2007)
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB
Wei-Chien Huang et al.
MOLECULAR CELL (2007)
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
Xiaobo Wang et al.
NATURE CELL BIOLOGY (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Loss of Ikkβ promotes migration and proliferation of mouse embryo fibroblast cells
Fei Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A critical role for IκB kinase α in the development of human and mouse squamous cell carcinomas
Bigang Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
The alternative NF-κB pathway from biochemistry to biology:: Pitfalls and promises for future drug development
Emmanuel Dejardin
BIOCHEMICAL PHARMACOLOGY (2006)
Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit
Katie Schumm et al.
EMBO JOURNAL (2006)
Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2
N. Mise et al.
ONCOGENE (2006)
Expression of Pitx2 in stromal cells is required for normal hematopoiesis
A Kieusseian et al.
BLOOD (2006)
RelA repression of RelB activity induces selective gene activation downstream of TNF receptors
E Jacque et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
NF-kappa B RelA poses epidermal proliferation riven by TNFR1 and JNK
JY Zhang et al.
GENES & DEVELOPMENT (2004)
Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53
W An et al.
CELL (2004)
P53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage
JM Espinosa et al.
MOLECULAR CELL (2003)
Modulation of NF-κB activity by exchange of dimers
S Saccani et al.
MOLECULAR CELL (2003)
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
M Dajee et al.
NATURE (2003)
P53 stabilization is decreased upon NFκB activation:: A role for NFκB in acquisition of resistance to chemotherapy
V Tergaonkar et al.
CANCER CELL (2002)
Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotype
MER Gapuzan et al.
ONCOGENE (2002)
NF-kappa B at the crossroads of life and death
M Karin et al.
NATURE IMMUNOLOGY (2002)
IKKα controls formation of the epidermis independently of NF-κB
YL Hu et al.
NATURE (2001)
Role of NF-κB in p53-mediated programmed cell death
KM Ryan et al.
NATURE (2000)
Share Paper
